Literature DB >> 22905681

Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease.

C Zizzo1, P Colomba, G Albeggiani, R Gallizzi, F Iemolo, D Nuzzo, S Vasto, C Caruso, G Duro.   

Abstract

Fabry disease (FD) is an underdiagnosed pathology due to its symptomatology that overlaps with various systemic and rheumatic disorders, including familial Mediterranean fever (FMF). We examined the Mediterranean fever (MEFV) and α-galactosidase A (GLA) genes, whose mutations are responsible for FMF and FD, respectively, in 42 unrelated patients diagnosed with FMF, which revealed significant ambiguity regarding some of the symptoms which are also present in FD. The objective of this study was to determine the spectrum of mutations present in these genes, in order to identify cases of mistaken diagnosis of FMF and/or missed diagnosis of FD. Ten out of 42 patients had one mutation in homozygosis or two different mutations in heterozygosis in the MEFV gene; 20/42 had a single heterozygous mutation, and 12/42 did not have genetic alterations in MEFV. The analysis of the GLA gene conducted on all the samples revealed that three subjects, and some members of their families, had two different exonic mutations associated with FD. Family studies allowed us to identify eight other cases of FD, bringing the total undiagnosed subjects to 11/53. Analyzing the MEFV and GLA genes in patients with clinical diagnoses of FMF proved to be fundamentally important for the reduction of diagnostic errors.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905681     DOI: 10.1111/j.1399-0004.2012.01940.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Lessons from two cases: is Fabry disease the correct diagnosis?

Authors:  Ertugrul Kiykim; Cigdem Ayse Aktuglu Zeybek; Tanyel Zubarioglu; Ahmet Aydin
Journal:  BMJ Case Rep       Date:  2015-05-12

Review 2.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

3.  Hypertension in adult Fabry's disease: is cardiotrophin-1 a diagnostic biomarker?

Authors:  Monica Gioia Marazzi; Emanuela Galliera; Elena Vianello; Elena Dozio; Andrea Stella; Guido Tettamanti; Lorenza Tacchini; Massimiliano M Corsi Romanelli
Journal:  Immun Ageing       Date:  2014-12-20       Impact factor: 6.400

4.  p.R301X Mutation and Variable Phenotypic Appearance of Fabry Disease.

Authors:  Ruya Ozelsancak; Bulent Uyar
Journal:  Am J Case Rep       Date:  2016-05-09

5.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.

Authors:  Elisabeth Fabian; Dietmar Schiller; Hermann Toplak; Michaela Brunner-Krainz; Franz Fazekas; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2017-11-21       Impact factor: 1.704

Review 6.  Fever in Children: Pearls and Pitfalls.

Authors:  Egidio Barbi; Pierluigi Marzuillo; Elena Neri; Samuele Naviglio; Baruch S Krauss
Journal:  Children (Basel)       Date:  2017-09-01

7.  Recurrent fever of unknown origin: An overlooked symptom of Fabry disease.

Authors:  Yi Luo; Di Wu; Min Shen
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

Review 8.  Current and experimental therapeutics for Fabry disease.

Authors:  Vanessa Castelli; Cosimo Andrea Stamerra; Michele d'Angelo; Annamaria Cimini; Claudio Ferri
Journal:  Clin Genet       Date:  2021-05-25       Impact factor: 4.438

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.